Ranibizumab - PDFSEARCH.IO - Document Search Engine

Ranibizumab
Results: 261

#	Item
231	Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Briefing Package for sBLA[removed]LUCENTIS (ranibizumab injection) Add to Reading List Source URL: www.fda.gov Language: English Ranibizumab Vascular endothelial growth factor Bevacizumab Macular degeneration Macular edema Genentech Diabetic retinopathy Methadone Macular telangiectasia Medicine Ophthalmology Health
232	1 DNA Way South San Francisco, CA[removed][removed]FAX: ([removed]August 28, 2006 Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:10 Ranibizumab Bevacizumab Vascular endothelial growth factor Genentech Retinopathy of prematurity Macular degeneration MedWatch Food and Drug Administration Endophthalmitis Medicine Health Pharmacology
233	Contact: Date: Reference: Pauline Constant: +[removed][removed] Add to Reading List Source URL: www.beuc.eu Language: English - Date: 2014-03-05 05:22:00 European Union Competition law Ranibizumab Pharmacology Medicine Political philosophy Consumer organizations Consumer protection Bevacizumab
234	Avastin vs Lucentis Letter sent to Vice-President Almunia on November 7th, 2013 Contact: Ilaria Passarani – [removed] Ref.: BEUC-X[removed]/2014 Add to Reading List Source URL: www.beuc.eu Language: English - Date: 2014-03-05 04:20:37 Health Genentech Macular degeneration Ranibizumab Novartis Hoffmann-La Roche Off-label use Presumed ocular histoplasmosis syndrome Medicine Pharmacology Bevacizumab
235	Avastin vs Lucentis Letter sent to Vice-President Almunia on March 17th, 2014 Contact: Ilaria Passarani – [removed] Ref.: BEUC-X[removed]/2014 Add to Reading List Source URL: www.beuc.eu Language: English - Date: 2014-03-18 12:19:39 Bevacizumab Ranibizumab Angiology Macular degeneration Pharmaceutical industry Vascular endothelial growth factor Directorate-General for Health and Consumers Committee for Medicinal Products for Human Use Consumer organization Medicine Congress of Deputies Health
236	Contact: Date: Reference: Pauline Constant: +[removed][removed] Add to Reading List Source URL: www.beuc.org Language: English - Date: 2014-03-05 05:22:00 European Union Competition law Ranibizumab Pharmacology Medicine Political philosophy Consumer organizations Consumer protection Bevacizumab
237	Avastin vs Lucentis Letter sent to Vice-President Almunia on March 17th, 2014 Contact: Ilaria Passarani – [removed] Ref.: BEUC-X[removed]/2014 Add to Reading List Source URL: www.beuc.org Language: English - Date: 2014-03-18 12:19:39 Bevacizumab Ranibizumab Angiology Macular degeneration Pharmaceutical industry Vascular endothelial growth factor Directorate-General for Health and Consumers Committee for Medicinal Products for Human Use Consumer organization Medicine Congress of Deputies Health
238	Avastin vs Lucentis Letter sent to Vice-President Almunia on November 7th, 2013 Contact: Ilaria Passarani – [removed] Ref.: BEUC-X[removed]/2014 Add to Reading List Source URL: www.beuc.org Language: English - Date: 2014-03-05 04:20:37 Health Genentech Macular degeneration Ranibizumab Novartis Hoffmann-La Roche Off-label use Presumed ocular histoplasmosis syndrome Medicine Pharmacology Bevacizumab
239	Department of Ophthalmology & Visual Sciences 25th Annual Research Day Monday, April 14, 2014 8:00 am – 3:30 pm Lord Nelson Hotel – Imperial Ballroom Program of Events Add to Reading List Source URL: ophthalmology.medicine.dal.ca Language: English - Date: 2014-04-08 08:02:12 Blindness Bevacizumab Eye surgery Glaucoma Ranibizumab Intraocular pressure Retina Macular degeneration Trabeculectomy Medicine Vision Ophthalmology
240	A Avastin versus Lucentis: Why It Matters lthough Lucentis is a remarkably safe and effective treatment for exudative macular degeneration, it could cost our health care system over $9 billion, which Add to Reading List Source URL: www.mrmcmed.org Language: English - Date: 2007-01-08 17:20:10 Bevacizumab Macular degeneration Ophthalmology Genentech Ranibizumab Choroidal neovascularization Vascular endothelial growth factor Presumed ocular histoplasmosis syndrome Off-label use Medicine Health Pharmacology